Zydus Lifesciences

Zydus Lifesciences, a Pharmaceutical Preparation Manufacturing company headquartered in India, reported approximately 328,547,000 kg CO2e in total emissions for 2025. This includes about 56,459,380 kg CO2e from Scope 1 emissions, 205,171,570 kg CO2e from Scope 2 emissions, and 66,915,740 kg CO2e from Scope 3 emissions.

For 2024, the company's Scope 1 emissions were approximately 65,458,740 kg CO2e, Scope 2 emissions were around 192,010,230 kg CO2e, and Scope 3 emissions were approximately 51,363,480 kg CO2e. In 2023, Zydus Lifesciences' Scope 1 emissions were about 56,053,320 kg CO2e, Scope 2 emissions were approximately 223,014,700 kg CO2e, and Scope 3 emissions were around 25,670,000 kg CO2e.

Looking further back, in 2022, the company's total emissions were approximately 259,815,000 kg CO2e, comprising about 59,573,000 kg CO2e from Scope 1, 191,170,000 kg CO2e from Scope 2, and 9,072,000 kg CO2e from Scope 3. For 2021, Zydus Lifesciences reported approximately 83,789,000 kg CO2e in Scope 1 emissions and 162,104,000 kg CO2e in Scope 2 emissions. In 2020, Scope 1 emissions were around 92,070,000 kg CO2e and Scope 2 emissions were about 168,794,000 kg CO2e.

Zydus Lifesciences has committed to achieving carbon neutrality in its operations (Scope 1 and 2 emissions) by FY2035. The company is also committed to setting near-term and net-zero targets, as indicated by its "Committed" status with the Science Based Targets initiative (SBTi). All reported emissions and commitments are directly from Zydus Lifesciences Limited.